
Montserrat Torrebadell Burriel
Investigador
Research group
Research line:
Leukemias and non-neoplastic hemopathies
Montserrat Torrebadell obtained in 1998 his Bachelor of Medicine and Surgery from the University of Barcelona. In 2005 Specialty in Hematology and Hemotherapy at the Hospital Clinico de Barcelona. In 2018 she presented his doctoral thesis at the University of Barcelona: "Anàlisi del valor pronòstic del perfil d'expressió gènica en la leucèmia mieloblàstica aguda de risc citogenètic intermig segons l'opció terapèutica post-remissió".
She currently works as an associate medical specialist, specialist in charge of the cytometry area. Laboratory Diagnostic Service, Hematology Laboratory of the Sant Joan de Déu Hospital in Barcelona since 2010. She is also coordinator of the Biological Group of Acute Myeloid Leukemia (LMA) of the Spanish Society of Pediatric Hematology and Oncology and the Spanish representative of the committee biological in LMA in the international cooperative group NOPHO, which is an integral part of the IBFM group. Her main research interests are: application of flow cytometry techniques in the diagnosis and monitoring of patients with leukemia, biological characterization of patients with AML.
Last Publications
- Esperanza-Cebollada E, Gomez-Gonzalez S, Pérez-Jaume S, Vega-García N, Vicente-Garces C, Richarte M, Rives-Solà S, Català-Temprano A, Torrebadell-Burriel M and Camós-Guijosa M A miRNA signature related to stemness identifies high-risk patients in paediatric acute myeloid leukaemia BRITISH JOURNAL OF HAEMATOLOGY . 202(1): 96-110.
- Vicente-Garces C, Maynou-Fernández J, Fernandez-Isern G, Esperanza-Cebollada E, Torrebadell-Burriel M, Català-Temprano A, Rives-Solà S, Camós-Guijosa M and Vega-García N Fusion InPipe, an integrative pipeline for gene fusion detection from RNA-seq data in acute pediatric leukemia Frontiers in Molecular Biosciences . 10: 1141310-1141310.
- Bueno C, Barrena S, Bataller A, Ortiz-Maldonado V, Elliott N, O'Byrne S, Wang G, Rovira M, Gutierrez-Agüera F, Trincado JL, Gonzalez M, Morgades M, Sorigué M, Barcena P, Zanetti SR, Torrebadell-Burriel M, Vega-García N, Rives-Solà S, Mallo M, Sole F, Mead AJ, Roberts I, Thongjuea S, Psaila B, Juan-Otero M, Delgado J, Urbano-Ispizua Á, Ribera JM, Orfao A, Roy A and Menéndez P CD34+CD19-CD22+ B-cell progenitors may underlie phenotypic escape in patients treated with CD19-directed therapies. Blood . 140(1): 38-44.
Projects
- Project name:
- Estudio multicéntrico fase 2 en pacientes pediátricos (0-18 años) con leucmeia linfoblástica aguda B CD19+ en recaída o refractaria
- Leader
- Susana Rives Solà
- Funding entities:
- Instituto de Salud Carlos III (ISCIII)
- Code
- ICI21/00033
- Starting - finishing date:
- 2022 - 2025
- Project name:
- Análisis de los factores pronósticos de fracaso del tratamiento tras terapia con células T con receptores antigénicos quiméricos (CAR-T) en pacientes pediátricos con leucemia linfoblástica aguda de línea B
- Leader
- Susana Rives Solà, Montserrat Torrebadell Burriel
- Funding entities:
- Instituto de Salud Carlos III (ISCIII), Fundació Privada per a la Recerca i la Docència Sant Joan de Déu - FSJD
- Code
- PI21/00218
- Starting - finishing date:
- 2022 - 2024
- Project name:
- SGR 2022-2024_Grup de recerca en tumors del desenvolupament
- Leader
- Jaume Mora Graupera
- Funding entities:
- Agaur - Agència de Gestió d'Ajuts Universitaris i de Recerca
- Code
- 2021 SGR 01612
- Starting - finishing date:
- 2022 - 2024
News
-
The hidden cells behind B-cell acute lymphoblastic leukemia relapse spotlighted for the first time
Drs. Susana Rives, Montserrat Torrebadell and Nerea Vega (IRSJD) participate in a study led by Dr. Pablo Menéndez, group leader at the Josep Carreras Leukaemia Research Institut, who has identified a previously noticed population of pre-leukemic cells might be responsible for some relapses in B-cell acute lymphoblastic leukemia (B-ALL).